The clinicopathological implications of serum IL-33 and sST2 as cancer biomarkers: A narrative review
Background: Interleukin (IL)-33 and its receptor, soluble suppression of tumorigenicity 2 (sST2), are key players in the immune response and cancer biology. IL-33 can promote tumorigenesis by enhancing cancer cell proliferation and modulating the immune environment to support tumor growth. Conversel...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-05-01
|
| Col·lecció: | Journal of Oral Biology and Craniofacial Research |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S221242682500079X |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|